Navigation Links
Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers, Upcoming Webinar Hosted by Xtalks
Date:8/15/2019

Serialization deadlines in the US and European Union have finally passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing whether their current serialization software is the best long-term solution.

Until now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. In the coming months, serialization systems will be tested for their ability to handle aggregation data, facilitate integration with distribution (internal and third-party logistics providers), integrate with downstream customers and handle complicated regulatory reporting requirements, such as the European Union’s Falsified Medicines Directive (EU FMD) and the Russian Federal Law No. 425-FZ.

Many players in the pharmaceutical industry have been feeling the pain of serialization solutions that are falling short. With the largest packaging-line installation base of any vendor, OPTEL often hears about these struggles: over-promised and under-delivered capabilities; high rates of issues and bugs; and the unexpected need to pay for costly “optional” tools and third-party resources to maintain a validated, high-performing solution.

Join Ron Watkins, Product Owner at Visit OPTEL and Bill Romano, Sales and Account Executive at OPTEL in a live session on Wednesday, September 11, 2019 at 9am EDT (2pm BST/UK) to better understand serialization options for global requirements. The featured speakers will discuss tested methodology and real-life case studies, as well as the immediate and longer-term benefits of moving to the OPTEL serialization platform.

For more information or to register for this free event, visit Understand Your Serialization Options and the Long and Short-term Benefit of Switching Providers.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/understand_your_serialization_options_and_the_long_and_short_term_benefit_of_switching_providers_upcoming_webinar_hosted_by_xtalks/prweb16500340.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. BRAIN initiative seeks tools to understand human thought, behavior, consciousness
2. Divide and define: Clues to understanding how stem cells produce different kinds of cells
3. Understanding the past and predicting the future by looking across space and time
4. OHSU scientists advance understanding of brain receptor; may help fight neurological disorders
5. Understanding the hearts rhythm
6. NIH fellowship helps researcher fight malaria, understand mosquito immunity
7. Unexpected discovery of the ways cells move could boost understanding of complex diseases
8. Honey bee gene targeting offers system to understand food-related behavior
9. CU study relies on twins and their parents to understand height-IQ connection
10. Drexel researchers looking inside vessels to understand bloods ebb and flow
11. Discovery of cell division master controller may improve understanding and treatment of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2020)... OLDSMAR, Fla. (PRWEB) , ... June 08, 2020 ... ... increased demand for masks and other protective measures to protect workers in the ... doctors and their dedicated staffs who valiantly risk their lives every day to ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... and solutions provider, today reported that the implementation of browser-based, enterprise label ... 100%, resulting in greater efficiency for global biotechnology company, bioMérieux. , Headquartered ...
(Date:5/28/2020)... Texas (PRWEB) , ... May 28, 2020 , ... ... announced today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT ... (ASCO) Annual Meeting which will take place virtually on May 29th, 2020. Dr. ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... ... develop a vaccine or drug treatment. In an effort to better understand the ... released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... (PRWEB) , ... June 22, 2020 , ... ... lead glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association ... of DRP-104; and, the other profiles the potent, consistent single agent activity in ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, ... through the use of proprietary clean viral vectors, recently announced a key manufacturing ... Greffex’s platform is the world’s most successful gene therapy delivery vehicle (vector) ...
Breaking Biology Technology: